Clinical Trial Update: OTR Tablet 40 mg Fasted-state Bioequivalence Study [Phase 1]

View source ↗

Summary

Phase 1 fasted-state bioequivalence study of OTR Tablet 40 mg completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• OTR Tablet 40 mg

Snippet

Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED | Results posted: 2019-10-31